Clinical Trial

Biomarkers for Predicting Mortality in Patients With Suspected Sepsis

Completed
View on ClinicalTrials.gov →
Summary
This retrospective study aimes to analyze the association of a number of routinely performed biomarkers with mortality in patients admitted to ICU with suspected sepsis. The study includes patients \>18 years of age, who had been admitted to the ICU with suspected sepsis. At ICU admission, baseline levels of PCT, CRP, albumin and lactate as well as WBC, neutrophil and lymphocyte counts will recorded.
Trial Details
NCT Number NCT07521306
Lead Sponsor Antalya Training and Research Hospital
Conditions Sepsis, Mortality, Biomarkers
Enrollment 250 participants
Start Date 2023-05-01
Primary Completion 2024-08-01 (estimated)
Study Completion 2024-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-09